CPhI South East Asia 2018

Join 5,000 key suppliers and buyers at CPhI South East Asia - the region's leading pharma solutions event

CPhI South East Asia offers you the chance to do business in a booming and expanding market, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics. The exhibition hosts a wide range of networking opportunities to grow your business including dedicated forums, an innovation gallery, seminars, and much more. Be a part of the region's premier pharmaceutical supply show,which brings together leading local and global pharma professionals to the South East Asian market. 

Co-located with ICSE, InnoPack, P-MEC and Hi South East Asia, all aspects of pharma are united in one location at CPhI South East Asia.

• ICSE: for contract manufacturing and services
• InnoPack: for pharmaceutical packaging and drug delivery systems
• P-MEC: for pharmaceutical machinery, technology and equipment
• Hi South East Asia: for nutraceuticals, functional food and beverages and dietary supplements

Why Exhibit

Increase your brand awareness: Show them the way

By exhibiting at CPhI South East Asia your brand will be made visible to over 5,000 attendees and 200 other exhibitors all in one place. Your business will also be visible to over 500 unique visitors per month on our website on the CPhI South East Asia Exhibitor List.

South East Asia Market Overview
 

1. Governments across Southeast Asia are introducing universal healthcare programs. This is driving rising demand for all categories of medicines, especially generic drugs. Since launching its mandatory healthcare coverage program (JKN) in 2014, Indonesia’s government healthcare spending has increased by 4%, and is forecast to reach USD 7.8 billion in 2016.
    
2. Implementation of the ASEAN Economic Community (AEC) will open up greater opportunities for trade and commerce among its member states. Healthcare, including pharmaceuticals, has been identified as a key sector where efforts to achieve harmonization of laws and standards will be concentrated.
    
3. ​Indonesia imports over 90% of the pharmaceutical ingredients it uses. The value of imports during the first half of 2015 saw a staggering rise of 17%, to USD 296 million.